Buy & Sell Affirm Holdings Inc (AFRM) – Affirm Holdings Inc Price Today
Aura AI Summary
Key Stats
- $21.84BMarket Cap
- FinancialsSector
- -18.99%3M Drawdown
- $28.45BEnterprise Value
- -Dividend Yield
- 21 daysTypical Hold Time
Affirm Holdings Inc (AFRM) is currently valued at a market capitalization of $21.84B, with an enterprise value of $28.45B. Over the past 52 weeks, Affirm Holdings Inc has traded between a low of $42.53 and a high of $92.18, highlighting its annual price range. Over the past three months, Affirm Holdings Inc has recorded a drawdown of -18.99%, reflecting recent price volatility. On average, investors hold Affirm Holdings Inc for approximately 21 days, indicating typical investor behavior on the platform.
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Most Recent News
Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...

Hansa Biopharma to present positive 12-month Phase 3 kidney transplant trial results at American Transplant Congress.
Hansa Biopharma announced that its Phase 3 ConfIdeS trial results for kidney transplantation in highly sensitized patients will be presented at the American Transplant Congress on June 22, 2026. The presentation will detail 12-month outcomes, includi...

TruBridge faces class action over financial errors and late report filing, shares drop 10.5%.
TruBridge, Inc. disclosed errors in its previously issued financial statements for 2023 and 2024, leading to a late filing of its 2025 annual report. The errors involve revenue recognition, contract costs, stock-based compensation, and capitalized so...
